SA, C., RC, R., PA, J., DB, S., & WP, M. (2023). Bevacizumab for Cerebral Radionecrosis: A Single-Center Experience. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 50(4), 573. https://doi.org/10.1017/cjn.2022.64
Chicago Style (17th ed.) CitationSA, Climans, Ramos RC, Jablonska PA, Shultz DB, and Mason WP. "Bevacizumab for Cerebral Radionecrosis: A Single-Center Experience." The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques 50, no. 4 (2023): 573. https://doi.org/10.1017/cjn.2022.64.
MLA (9th ed.) CitationSA, Climans, et al. "Bevacizumab for Cerebral Radionecrosis: A Single-Center Experience." The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques, vol. 50, no. 4, 2023, p. 573, https://doi.org/10.1017/cjn.2022.64.